A Blog by AMCP CEO Susan Cantrell


AMCP_Beyond 
 

 


Eye on the Hill: AMCP Sees Progress in PIE Bill and Will Continue to Promote Comprehensive Pharmacy Benefit in Health Care Reform Efforts

 

April 11, 2017 

Whoever said, “May you live in interesting times,” could have been talking about Congressional health care policy debates circa 2017. Never a dull moment!

Many things are happening on the health care legislative front, and AMCP has been in the thick of it. I am delighted to report that we are seeing major movement in our efforts to better facilitate the sharing of clinical and economic information between biopharmaceutical companies and health care decision makers.

On April 6, Rep. Brett Guthrie (R-KY) introduced H.R.2026, the "Pharmaceutical Information Exchange (PIE) Act of 2017". The bill aims to improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers.

We applaud Congressman Guthrie for taking the lead on this important initiative. The PIE Act will help AMCP members better care for the patient populations they serve by aiding in forecasting and budgeting, and by enabling the implementation of value-based contracts and expediting coverage decisions for emerging therapies granted breakthrough designation immediately upon FDA approval. AMCP is proud to have led on this issue on behalf of our members.

The bill’s language closely aligns with AMCP’s consensus recommendations, released in January, to allow biopharmaceutical companies to proactively share clinical and economic information with population health decision makers on emerging therapies in advance of Food and Drug Administration (FDA) approval, an area that is significantly restricted by current federal laws and FDA regulations. You can read the recommendations here: http://bit.ly/PIEproceedings.

In the coming weeks, we will work to build bipartisan support to pass this legislation. I am proud to say that AMCP is in the thick of efforts to move the U.S. closer and closer to a value-based health care system where decisions are made using all of the available evidence to help improve health care for all.

On a larger front, the dominant health care question for 2017 remains the same: what if anything will replace the Affordable Care Act (ACA)? While Congress’s recent efforts to replace the ACA failed, GOP lawmakers are now considering new efforts to repeal and replace this landmark health care reform. Whatever transpires, AMCP will continue to advocate for the inclusion of a comprehensive pharmacy benefit that uses managed care pharmacy principles and practices. This was the message that AMCP board members, volunteers and staff took to Capitol Hill last month for our Legislative Days event. During our meetings in more than 53 House and Senate offices, we made three essential points:

●  First, we support a comprehensive prescription drug benefit in any new legislation that improves outcomes while ensuring the wise use of health care dollars.

●  Second, managed care pharmacy professionals have the expertise necessary to help lawmakers develop policies for an effective pharmaceutical benefit under any new health care reform bill.

●  Third, the nation must continue moving towards a value-based health care system that promotes and funds comparative effectiveness research to make more informed decisions.

Interesting times, indeed!


Susan A. Cantrell, RPh, CAE is CEO of the Academy of Managed Care Pharmacy 


 


AMCP Celebrates Early Win: FDA Issues Draft Guidance to Improve Communications Between Biopharmaceutical Companies and Population Health Decision Makers

 

March 1, 2017 

Every morning — like many of you — I settle behind my desk, take a sip of coffee and read the AMCP Daily Dose. This publication, full of valuable news and information, frequently highlights issues and individuals we’re featuring at our Annual Meeting, March 27-30, in Denver. Several caught my eye recently. ... Read more 


 


AMCP Celebrates Early Win: FDA Issues Draft Guidance to Improve Communications Between Biopharmaceutical Companies and Population Health Decision Makers

 

February 1, 2017 

Sometimes the best laid plans are upended when you least expect it!

In mid-January, the FDA released draft guidance to facilitate the sharing of information between biopharmaceutical companies and population health decision makers. To say we were pleasantly surprised is an understatement. ... Read more 


 


Making PIE to Better Serve Patients

 

January 11, 2017 

Let’s imagine you’re a big city mayor and it’s time to order a new fleet of police cars for next year. Applying due diligence, you set out to compare various models from a variety of manufacturers. ... Read more 


 


Century Cures Act Advances AMCP's FDAMA Goals, Improves Value-Based Communications Between Manufacturers and Managed Care Pharmacy

 

December 22, 2016 

Who says Congress can’t get anything done…and with bipartisan support to boot? With impressive speed and purpose, the House and Senate overwhelmingly passed the 21st Century Cures Act in the waning days of the 114th Congress, followed by President Obama’s prompt signature. ... Read more 


 


Pharmacy Profession Comes Together to Help Document and Improve Patient Outcomes Through Medication Therapy Management

 

November 7, 2016 

People can accomplish remarkable things when they work toward a common goal. That’s what happened recently when a diverse group of pharmacy stakeholders gathered to develop standardized terms for medication therapy management (MTM) services. ... Read more 


 


AMCP really knows how to get things done!

 

October 13, 2016 

Not long ago a respected individual in the health care arena told one of my senior staff: “Compared to other associations I work with, AMCP really knows how to get things done.” You cannot imagine how proud I felt ... Read more 


 


AMCP Volunteers Are a Happy Lot

 

September 20, 2016 

There are many ways to measure the health and vitality of a professional association. The most crucial indicators, I’ve found, center on the engagement of an organization’s volunteers. This can be measured in the number of volunteer opportunities provided, the number of members who sign up, and the level of satisfaction they get from volunteering. ... Read more 


 


The Post Cites Pharmacists’ Expanding Role on Medical Teams

 

August 26, 2016 

Last week I saw a headline that jumped off the page: “America’s other drug problem: Giving the elderly too many prescriptions” (Washington Post, Aug. 15). I couldn’t read it fast enough and encourage members to do likewise, as it highlights two of the most important developments in health care. ... Read more 


 


Seizing Opportunity: AMCP Nexus 2016 Offers Knowledge, Advancement and More

 

August 3, 2016 

“Healing is a matter of time, but it is sometimes also a matter of opportunity,” said the great Hippocrates, father of western medicine.

Opportunity, in fact, is a crucial element in the work that managed care pharmacy professionals engage in every day to improve the health, wellbeing and “healing” of millions of patients. We seize opportunities to find the right medicines for the right patients at the right time. ... Read more 


 


BRC Now Lets You Look It Up

 

July 13, 2016 

It was only ten years ago when biosimilars were so new that the New York Times described them as “so-called.” As late as five years ago newspapers put quotation marks around the term, as in “biosimilars.” At the time some still called them “follow-on” biopharmaceutics. ... Read more 


 


Is FDAMA Section 114 Finally Ready for Prime Time?

 

June 24, 2016 

Information is the life blood of managed care pharmacy. Of the “competent and reliable scientific” variety, that is.

Our profession operates best when we have broad access to the latest evidence-based data on the multitude of products coming to market today. We can plan, we can assess. With this information, managed care pharmacy professionals can help health care providers and patients select the right drug for the right patient at the right time, while making appropriate use of our scarce health care dollars. ... Read more 


 


Getting it straight with the updated AMCP Format!

 

May 19, 2016 

Using the best evidence possible to make informed health care decisions is a hallmark of managed care pharmacy. But making sense of the data often is no easy task, especially when it comes to analyzing pharmaceuticals and the value they bring to patients and the health care system... Read more 


 


CEO Susan Cantrell Addresses AMCP Annual Meeting

 

May 10, 2016 

New&Views announces a new monthly column by CEO Susan A. Cantrell, RPh, CAE, on breaking news and critical issues. Her first column presents her recent address―her first to the membership―at AMCP’s recent Annual Meeting.

“It is truly an honor to be standing before you today as the Academy’s new CEO. While new to the AMCP staff, I’ve been an observer and at times a participant in the terrific work of this organization. ..." Read more.